Copyright © 1997 by the European Society of Cardiology.
© 1997 The European Society of Cardiology
Calcium antagonists and atherosclerosis
Experimental evidence
Institute of Pharmacological Sciences, University of Milano and Centro per lo Studio delle Vasculopatie Periferiche Ospedale Bassini, Milano, Italy
Correspondence: Prof. Alberico L. Catapano, Institute of Pharmacological Sciences, Via Balzaretti, 9, 20133 Milano, Italy
Accumulation of cholesterol and calcium is the hallmark of atherosclerosis. Ca2+ antagonists lessen the severity of experimentally induced atherosclerosis in a variety of animal models, including hypercholesterolaemic animals. They also reduce cholesterol accumulation in the arterial wall, but without affecting plasma lipids. This review briefly discusses in vitro and in vivo experimental studies on the anti-atherosclerotic properties of Ca2+ antagonists and outlines mechanisms by which these compounds affect cellular lipid metabolism.
Key Words: Lipids lipoprotein LDL LDL-receptor cholesterol ACAT